Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome

Abstract

In obese individuals with MS, fat mass reduction was associated with short-term improvements in depressive and anxiety symptoms. <i>Trial Registration</i> Registered at ClinicalTrials.gov, NCT01598233.